Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Says German Court Finds Thermo-Finnigan s Ion Traps Infringe on Mass Spec Patent

NEW YORK, April 12 – A German court ruled Thursday that Thermo-Finnigan's GCQ and LCQ ion traps infringe upon Bruker Daltonics’ European patent for ion trap mass spectrometry and ordered Thermo-Finnigan to pay Bruker damages and court costs, Bruker said.

Bruker sued Bremen, Germany-based Thermo Finnigan and its affiliates in Dusseldorf District Court for patent infringement of its patent EP 0336 990, which relates to ion trap technology.

Earlier, Thermo-Finnigan had unsuccessfully sought to invalidate this patent in Germany, according to Bruker.

In an official statement released Thursday, Bruker, of Billerica, Mass., said it expected the court to order Thermo-Finnigan and its German affiliates “to cease and desist from offering, distributing, using, or importing any GCQ or LCQ-series ion traps in Germany.”

The amount of Thermo Finnegan’s liability will be determined by the court at a later date.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.